Davies CC, Harvey E, McMahon RFT, Finegan KG, Connor F, Davis RJ, Tuveson DA, Tournier C. (2014) Impaired JNK signaling cooperates with KrasG12D expression to accelerate pancreatic ductal adenocarcinoma. Cancer Res. 74, 3344-56.
Okamura D, Mochizuki K, Taniguchi H, Tokitake Y, Ikeda M, Yamada Y, Tournier C, Yamaguchi S, Tada T, Scholer HR, Matsui Y. (2012) REST and its downstream molecule Mek5 regulate survival of primordial germ cells. Dev Biol. 372, 190-202.
Perez-Madrigal D, Finegan KG, Paramo B, Tournier C. (2012) The extracellular-regulated protein kinase 5 (ERK5) promotes cell proliferation through the down-regulation of inhibitors of cyclin dependent protein kinases (CDKs). Cell Signal. 24, 2360-2368.
Hübner A, Mulholland DJ, Standen CL, Karasarides M, Cavanagh-Kyros J, Barrett T, Chi H, Greiner DL, Tournier C, Sawyers CL, Flavell RA, Wu H, Davis RJ. (2012) JNK and PTEN cooperatively control the development of invasive adenocarcinoma of the prostate. Proc Natl Acad Sci U S A. 109, 12046-12051.
Le NT, Takei Y, Shishido T, Woo CH, Chang E, Heo KS, Lee H, Lu Y, Morrell C, Oikawa M, McClain C, Wang X, Tournier C, Molina CA, Taunton J, Yan C, Fujiwara K, Patterson C, Yang J, Abe J. (2012) p90RSK targets the ERK5-CHIP ubiquitin E3 ligase activity in diabetic hearts and promotes cardiac apoptosis and dysfunction. Circ. Res. 110, 536-550.
Mazzitelli S, Xu P, Ferrer I, Davis RJ, Tournier C (2011) The loss of JNK activity prevents the amyloidogenic cleavage of APP and the formation of amyloid plaques in vivo. J. Neurosci. 31, 16969 –16976.
Ahn YH, Yang Y, Gibbons DL, Creighton CJ, Yang F, Wistuba II, Lin W, Thilaganathan N, Alvarez CA, Roybal J, Goldsmith EJ, Tournier C, Kurie JM (2011) Map2k4 functions as a tumor suppressor in lung adenocarcinoma and inhibits tumor cell invasion by decreasing PPARg2. Mol. Cell. Biol. 31, 4270-4285.
Iñesta-Vaquera FA, Campbell DG, Tournier C, Gómez N, Lizcano JM, Cuenda A (2010) Alternative ERK5 regulation by phosphorylation during the cell cycle. Cell Signal 22, 1829-1837.
Finegan KG, Tournier C (2010) The mitogen-activated protein kinase kinase 4 (MKK4) has a pro-oncogenic role in skin cancer. Cancer Res. 70, 5797-5806.
Finegan KG, Wang X, Lee E-J, Robinson AC, Tournier C (2009) Regulation of neuronal survival by the extracellular signal-regulated protein kinase 5. Cell Death Differ. 16, 674-683.
Wang X, Nadarajah B, Robinson AC, McColl BW, Jin JW, Dajas-Bailador F, Boot-Handford RP, Tournier C (2007) Targeted deletion of the mitogen-activated protein kinase kinase 4 gene in the nervous system causes severe brain developmental defects and premature death. Mol. Cell. Biol. 27, 7935-7946.
Wang X, Finegan KG, Robinson AC, Knowles L, Khosravi-Far R, Hinchliffe KA, Boot-Handford RP, Tournier C (2006) Activation of extracellular signal-regulated protein kinase 5 down-regulates FasL upon osmotic stress. Cell Death Differ. 13, 2099-2108.
Seyfried J, Wang X, Kharebava G, Tournier C (2005) A novel MAPK docking site in the N-terminus of MEK5a organizes the components of the ERK5 signaling pathway. Mol. Cell. Biol. 25, 9820-9828.